AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

Oregon Public Broadcasting

Jan 31, 2023

After 20 years and $200 billion in revenue, Humira - an injectable treatment for rheumatoid arthritis and several other autoimmune conditions - has lost its monopoly. Early Tuesday…